Discontinuation report GLUCONORM 2.0MG
Report ID | 201489 |
Drug Identification Number | 02239926 |
Brand name | GLUCONORM 2.0MG |
Common or Proper name | Gluconorm |
Company Name | NOVO NORDISK CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | REPAGLINIDE |
Strength(s) | 2.0MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 90 |
ATC code | A10BX |
ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2024-05-31 |
Actual discontinuation date | |
Remaining supply date | |
Discontinuation status | To be discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 101-2476 ARGENTIA ROAD MISSISSAUGA, ONTARIO CANADA L5N 6M1 |
Company contact information | 1 800 465 4334 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2024-01-26 | French | Compare |
v3 | 2024-01-26 | English | Compare |
v2 | 2023-08-09 | French | Compare |
v1 | 2023-08-09 | English | Compare |
Showing 1 to 4 of 4